Diamyd Medical (Germany) Top Insiders
DMN Stock | EUR 1.07 0.01 0.94% |
Diamyd Medical employs about 20 people. The company is managed by 6 executives with a total tenure of roughly 47 years, averaging almost 7.0 years of service per executive, having 3.33 employees per reported executive. Examination of Diamyd Medical's management performance can provide insight into the company performance.
Ulf MBA Insider CEO Pres |
Anton Lindqvist Insider Chief Officer |
Diamyd |
Diamyd Medical Management Team Effectiveness
The company has return on total asset (ROA) of (0.2531) % which means that it has lost $0.2531 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4155) %, meaning that it generated substantial loss on money invested by shareholders. Diamyd Medical's management efficiency ratios could be used to measure how well Diamyd Medical manages its routine affairs as well as how well it operates its assets and liabilities.Diamyd Medical Workforce Comparison
Diamyd Medical AB is one of the top stocks in number of employees category among its peers. The total workforce of Biotechnology industry is currently estimated at about 62,638. Diamyd Medical adds roughly 20.0 in number of employees claiming only tiny portion of stocks in Biotechnology industry.
Diamyd Medical AB Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Diamyd Medical AB Price Series Summation is a cross summation of Diamyd Medical price series and its benchmark/peer.
Diamyd Medical Notable Stakeholders
A Diamyd Medical stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Diamyd Medical often face trade-offs trying to please all of them. Diamyd Medical's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Diamyd Medical's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Ulf MBA | CEO Pres | Profile | |
Anton Lindqvist | Chief Officer | Profile | |
Martina Widman | Chief Officer | Profile | |
Anna BSc | Chief Officer | Profile | |
Christoph Nowak | Chief Officer | Profile | |
Eva Karlstrom | Chief Officer | Profile |
About Diamyd Medical Management Performance
The success or failure of an entity such as Diamyd Medical AB often depends on how effective the management is. Diamyd Medical management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Diamyd management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Diamyd management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Diamyd Medical AB , a diabetes company, engages in the development of combination therapies for the treatment of autoimmune diabetes. The company was formerly known as Diamyd Therapeutics AB and changed its name to Diamyd Medical AB in April 2013. DIAMYD MEDICAL operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 6 people.
Diamyd Medical Workforce Analysis
Traditionally, organizations such as Diamyd Medical use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Diamyd Medical within its industry.Diamyd Medical Manpower Efficiency
Return on Diamyd Medical Manpower
Revenue Per Employee | 22.7K | |
Revenue Per Executive | 75.7K | |
Net Loss Per Employee | 5.2M | |
Net Loss Per Executive | 17.3M |
Complementary Tools for Diamyd Stock analysis
When running Diamyd Medical's price analysis, check to measure Diamyd Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Diamyd Medical is operating at the current time. Most of Diamyd Medical's value examination focuses on studying past and present price action to predict the probability of Diamyd Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Diamyd Medical's price. Additionally, you may evaluate how the addition of Diamyd Medical to your portfolios can decrease your overall portfolio volatility.
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |